Zituvio Tablet
Product Images NDC 70771-1772

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zituvio (NDC 70771-1772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (E935111f 7b36 4991 Bc5b 2a45eecc9570 01)

Chemical structure of Sitagliptin, the active ingredient in ZITUVIO tablets. The diagram depicts the molecular framework including trifluoromethyl and fluorophenyl groups, consistent with Sitagliptin's chemical composition.*

FDA Label Image

Image (E935111f 7b36 4991 Bc5b 2a45eecc9570 02)

A line graph showing the least squares mean change from baseline over 24 weeks for various treatments including placebo, metformin at different dosages, sitagliptin 100 mg once daily, and combinations of sitagliptin 50 mg twice daily with metformin 500 mg or 1000 mg twice daily. The y-axis represents LS mean change from baseline, and the x-axis represents time in weeks.*

FDA Label Image

Image (E935111f 7b36 4991 Bc5b 2a45eecc9570 03)

A line graph showing the least squares (LS) mean change from baseline over a 52-week period. The x-axis represents weeks from 0 to 52, and the y-axis shows the LS mean change from baseline, ranging approximately from 0.0 to -1.5. Two data series are plotted with distinct markers, both showing a downward trend reaching the lowest point around week 30, followed by a slight upward trend towards week 52.*

FDA Label Image

25 mg Label (E935111f 7b36 4991 Bc5b 2a45eecc9570 04)

Label for Zituvio (sitagliptin) Tablets, 25 mg oral tablets by Zydus Lifesciences Limited. The label indicates a package of 90 tablets, with instructions to dispense the enclosed medication guide and to use the product within 3 months of opening. Storage and dosage information is also included.*

FDA Label Image

50 mg Label (E935111f 7b36 4991 Bc5b 2a45eecc9570 05)

Packaging label for ZITUVIO (sitagliptin) Tablets, 50 mg oral tablets. The label notes that the package contains 90 tablets and includes instructions to dispense the enclosed medication guide to each patient. It is labeled by Zydus Lifesciences Ltd., with storage information and usage warnings printed on the right side.*

FDA Label Image

100 mg Label (E935111f 7b36 4991 Bc5b 2a45eecc9570 06)

Packaging label for ZITUVIO (sitagliptin) Tablets 100 mg oral tablets by Zydus Lifesciences Limited. The label shows a package containing 90 tablets with instructions to dispense the enclosed Medication Guide and use within 3 months of opening. It includes storage conditions and child-resistant packaging details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.